Kathryn Collison

Kathryn Collison is a Senior Global Clinical Operations Program Director at AstraZeneca, leading clinical study design and development since 2022. With previous experience as a Medical Affairs Scientific Director at GSK and extensive roles at AstraZeneca, including Study Delivery Leader, Kathryn has contributed to various therapeutic areas such as respiratory and cardiovascular. Kathryn's career began as a Metrologist at Laboratory Management Systems, Inc, and has included positions at DuPont Pharmaceuticals and Aventis Pharmaceuticals, showcasing a strong background in clinical operations and pharmacokinetics. They hold a Master of Public Health from The Johns Hopkins University, along with a Bachelor's in Medical Technology from the University of Delaware and a Master's Certificate in Project Management from Villanova University.